<DOC>
	<DOCNO>NCT01264445</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , immunogenicity adjuvanted GSK investigational HIV vaccine Ad35-GRIN 4 different regimen month 1 , 2 , 3 , 4 .</brief_summary>
	<brief_title>Safety Immunogenicity Study 2 Investigational Preventive HIV Vaccines</brief_title>
	<detailed_description>Volunteers screen 42 day vaccination ( 90 day Ad35 neutralize antibody ) follow 12 month last vaccination ( 16 month total participation ) . It estimate take approximately 5 month complete enrolment .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Healthy male female , assess medical history , physical exam , laboratory test 2 . At least 18 year age day screen reach his/her 41st birthday day first vaccination 3 . Willing comply requirement protocol available followup plan duration study ( screen plus 16 month ) 4 . In opinion Principal Investigator designee base Assessment Informed Consent Understanding result , understood information provide potential risk link vaccination participation trial . Written informed consent need provide volunteer studyrelated procedure perform 5 . Willing undergo HIV testing , risk reduction counselling , receive HIV test result commit maintain low risk behaviour trial duration 6 . If female childbearing potential ( menopausal anatomically sterile ) , willing use effective nonbarrier method contraception ( hormonal contraceptive ; intrauterine device ) , screen four month last vaccination . All female volunteer must willing undergo urine pregnancy test time point indicate study protocol must test negative prior vaccination . 7 . If sexually active male ( anatomically sterile ) , willing use effective method contraception ( consistent condom use ) day first vaccination 4 month last vaccination 8 . Willing forgo donation blood tissue study , test HIV positive vaccination , antiHIV antibody titres become undetectable 1 . Confirmed HIV1 HIV2 infection 2 . Any clinically relevant abnormality history examination include history immunodeficiency , malignancy autoimmune disease ; use systemic corticosteroid ( &lt; 2 week use topical inhaled steroid permit ) ; immunosuppressive , anticancer , antituberculosis medication consider significant investigator within previous 6 month 3 . Any clinically significant acute chronic medical condition consider progressive , opinion investigator , make volunteer unsuitable participation study 4 . Detection Ad35specific serum neutralize antibody 5 . Reported highrisk behaviour HIV infection within 6 month prior first vaccination , define protocol . 6 . If female , pregnant planning pregnancy within 4 month last vaccination ; lactate 7 . Unstable asthma ( e.g . sudden acute attack occur without obvious trigger ) asthma require : Daily steroid long act betaagonist prevention Hospitalization last two year 8 . Bleeding disorder diagnose physician e.g. , factor deficiency , coagulopathy platelet disorder require special precaution . ( A volunteer state easy bruise bleeding , formal diagnosis intramuscular ( IM ) injection blood draw without adverse experience eligible ) 9 . History splenectomy 10 . Any abnormal laboratory parameter define protocol ; 11 . Receipt liveattenuated vaccine within previous 60 day ( live attenuate flu vaccine within 14 day ) plan receipt within 60 day vaccination Investigational Product ; receipt vaccine ( e.g . pneumococcal ) , allergy treatment antigen injection tuberculin skin test within previous 14 day plan receipt within 14 day vaccination Investigational Product 12 . Receipt blood transfusion bloodderived product within previous 6 month 13 . Participation another clinical trial Investigational Product currently , within previous 3 month expect participation study 14 . Prior receipt another investigational HIV vaccine candidate ( note : receipt HIV vaccine placebo exclude volunteer participation documentation available IAVI Medical Monitor give approval ) 15 . History severe local systemic reactogenicity vaccine ( e.g . anaphylaxis , respiratory difficulty , angioedema ) 16 . History severe allergic reaction substance require hospitalization emergency medical care ( e.g . StevenJohnson syndrome , bronchospasm hypotension ) 17 . Known sensitivity sulphite , aspirin aminoglycoside antibiotic ( e.g . amikacin , arbekacin , gentamicin , kanamycin , neomycin , netilmicin , paromomycin , streptomycin , tobramycin , etc ) 18 . Confirmed diagnosis active hepatitis B ( HBsAg ) , hepatitis C ( HCV antibody ) , active syphilis active tuberculosis 19 . History severe neurological disorder , seizure psychiatric disorder ( e.g schizophrenia , severe psychosis , bipolar disorder require therapy , suicidal attempt ideation ) 20 . For volunteer clinical centre participate ophthalmic examination , clinically significant abnormality find baseline ophthalmic examination .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>HIV</keyword>
</DOC>